Ocular Regenerative Medicine Institute


photoreceptorintegration

Harvard Medical School Department of Ophthalmology


CO-DIRECTORS
Demetrios G. Vavvas, M.D., Ph.D.
Michael J. Young, Ph.D.

Tissue and stem cell therapies hold enormous promise for repairing ocular tissues. Investigators in the Ocular Regenerative Medicine Institute (ORMI) lead the effort to develop revolutionary methods to regenerate eye tissues for various diseases, including age-related macular degeneration (AMD), glaucoma, corneal disease, and ocular cancer. They significantly advanced the understanding of tissue and stem cell transplantation in the retina—particularly in terms of graft survival and the formation of functional neural connections after transplantation. Our investigators are also developing biomaterials that can be used for delivering neuroprotective agents or stem cells to the retina; the engineered biomaterials have also been shown to promote survival and functional growth of neurons after transplantation.

Image: Donor photoreceptor integration into recipient retina.

Symposium on Ocular Regeneration

Symposium on Ocular Regeneration

Oct 11, 2018

The Biennial International Symposium on Ocular Regeneration presents the current and future state of regeneration and stem cells in eye diseases.

Learn more about the event >>

ORMI: Working Toward the Promise of Second Sight

Click to access the latest issues of EyeWitness

Read more about the Ocular Regenerative Medicine Institute in the October 2014 Issue of EyeWitness: News from the Harvared Medical School Department of Ophthalmology.